By Heather Mack

SmithRx, which has developed a platform for drug price negotiation and sales, has raised $9 million in Series A funding.

Founders Fund led the investment, with participation from Blumberg Capital, Box Group, NextGen Venture Partners and others. The funding is to be used for expansion efforts.

Read more.